ARCHIVES

National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

Stereotactic Body Radiotherapy Could Improve Overall Survival

July 29, 2011

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Utah, NIEHS Report Finding BRACA1 Gene For Familial Breast, Ovarian Cancer

September 23, 1994

MD Anderson President Ronald DePinho: “Some of the Feedback was Humbling”

March 29, 2013

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

Biggest NCI Budget Brings Large Headache: More Commitments, Rising Costs, Opportunities

December 8, 1989